Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001077183-22-000049

Chief Financial Officer sold 3,209 shares at $18.29 ($58,693)

  • Chief Financial Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bonello William · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-07 Sale : show line 1 in the form −3,209 $18.29 $58,693 98,516 D
2022-03-08 Exercise or conversion : show line 2 in the form +5,000 $7.52 $37,600 103,516 D
Open-market sales · 3,209 sh · avg $18.29 · $58,693

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-08 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −5,000 5,727 D
Loading xslF345X03/wf-form4_164686693130490.xml…